The research will take place at the Icahn School of Medicine at Mount Sinai, New York
Despite uncertainty around federal prosecution, banking activity has steadily increased in states with adult-use cannabis laws
The results show that smoking pot can produce up to a 16% reduction in eye pressure
Cannabis consumers were more likely to choose higher-effort tasks
During the pandemic, women were about twice as likely as men to use cannabis more frequently to manage anxiety
NFL players aren't allowed to participate in the research
A new Deloitte report highlights pot's massive economic contributions, while operators continue to battle regulatory absurdities
But the results reinforce the view that laws based on blood-THC tests aren't supported by evidence
The study adds to a body of emerging research suggesting pot is effective in reducing opioid use
Other studies have shown similar outcomes but haven't been consistent
Substances helped lower people's anxiety and shame, but also lead to riskier sexual behaviours
Researchers warn against heavy use, especially in youth
Two separate trials will look at MDMA for alcohol use and PTSD, as well as psilocybin-assisted therapy for anorexia nervosa
The largest increase in drivers with moderate injuries was seen in men over 50
A recent study suggests the method could be used in roadside assessments of impaired driving from THC
Certain cannabinoids appear to block the virus from attaching to the 'doorway' of the cell
Following the trial's approval from Health Canada, psychedelic practitioners can now apply to be research subjects
The research shows a sharp uptick in young children going to hospital, in the period after legal edibles came to market
The stronger preference for flower is steady across demographics
Currently treatments are largely insufficient, so care providers encourage more research despite stigma
Canadians' attitudes haven't shifted much over the past year
Lockdowns and stimulus cheques were responsible for an irregular boost in buying weed
Some study participants stopped using cannabis out of fear of potential harm to the fetus, while others stopped because of social stigma, guilt and health reasons
Olorinab is a CB2 receptor agonist in a Phase 2 trial for IBS
The Indigenous-led research team has partnered with Woodland Cree First Nation and Indigenous Bloom
A majority of cannabis consumers combine weed and working out, according to earlier research
Compared to non-consumers, people who used cannabis 20 days a month were more likely to experience both extremes of sleep duration
The new facility will feature the firm's ketamine-assisted therapy program, as well as a range of health and lifestyle services
And some terpenes have painkilling effects without interacting with cannabinoid receptors
While THC can cause temporary dose-dependent psychotic symptoms, researchers note that some clinical findings suggest CBD has a different effect
Terpenes are only part of what gives some types of weed their unique smells and other related properties
The research casts doubt on currently used methods for detecting impairment
There are more than 3,800 studies on weed published this year already, surpassing a record set in 2020
Research funded by MindMed suggests some antidepressants can reduce the unwanted side effects of psychedelics
The methods will be available as part of third-party client services
In spite of warnings from major agencies on the dangers of delta-8 THC, researchers say it has therapeutic potential
Some are criticizing researcher Stamets for trying to capitalize on the phenomenon of 'stacking,' where psychedelics are paired with health supplements
A total 27 million cannabis vape units were sold over the three-month period in both countries, generating over US$900 million in revenue
72% of cannabis users say that everyone, or almost everyone, they know consumes cannabis
Cannabis sales have been 25% higher than estimated revenue if the pandemic didn't happen








































